A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations

• Tao Xie ,

  * E-mail: tao.xie@pfizer.com (TX); hodgson.graeme@gmail.com (JGH)

  Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

  ⨯
• Giovanni d’ Ario,

  Affiliation Swiss Institute of Bioinformatics, Lausanne, Switzerland

  ⨯
• John R. Lamb,

  Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

  ⨯
• Eric Martin,

  Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

  ⨯
• Kai Wang,

  Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

  ⨯
• Sabine Tejpar,

  Affiliation University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium

  ⨯
• Mauro Delorenzi,

  Affiliations Swiss Institute of Bioinformatics, Lausanne, Switzerland, Lausanne University Medical Center, Lausanne, Switzerland

  ⨯
• Fred T. Bosman,

  Affiliation Lausanne University Medical Center, Lausanne, Switzerland

  ⨯
• Arnaud D. Roth,

  Affiliation Geneva University Hospital, Geneva, Switzerland

  ⨯
• Pu Yan,

  Affiliation Lausanne University Medical Center, Lausanne, Switzerland

  ⨯
• Stephanie Bougel,

  Affiliation Lausanne University Medical Center, Lausanne, Switzerland

  ⨯
• Antonio Fabio Di Narzo,

  Affiliation Swiss Institute of Bioinformatics, Lausanne, Switzerland

  ⨯
• Vlad Popovici,

  Affiliation Swiss Institute of Bioinformatics, Lausanne, Switzerland

  ⨯
• Eva Budinská,

  Affiliation Swiss Institute of Bioinformatics, Lausanne, Switzerland

  ⨯
• Mao Mao,

  Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

  ⨯
• Scott L. Weinrich,

  Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

  ⨯
• Paul A. Rejto,

  Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

  ⨯
•  [ ... ],
• J. Graeme Hodgson

  * E-mail: tao.xie@pfizer.com (TX); hodgson.graeme@gmail.com (JGH)

  Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

  ⨯
• [ view all ]
• [ view less ]